These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1566357)

  • 21. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell tolerance induced in nude mice grafted with thymic epithelium.
    Robinson JH; Chapman CJ; Loveland BE; Jordan RK
    Immunology; 1992 Feb; 75(2):318-24. PubMed ID: 1551693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The failure of skin grafting to break tolerance to class I-disparate renal allografts in miniature swine despite inducing marked antidonor cellular immunity.
    Rosengard BR; Kortz EO; Ojikutu CA; Guzzetta PC; Sundt TM; Smith CV; Nakajima K; Boorstein SM; Hill GS; Sachs DH
    Transplantation; 1991 Dec; 52(6):1044-52. PubMed ID: 1750067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine-induced tolerance in experimental organ transplantation. Evidence of diminished donor-specific cytotoxicity relative to donor-specific proliferative response.
    Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
    J Immunol; 1987 Jul; 139(2):332-7. PubMed ID: 2955037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergism between minor and major histocompatibility antigens in the rejection of cultured allografts.
    La Rosa FG; Talmage DW
    Transplantation; 1985 May; 39(5):480-5. PubMed ID: 3992648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of cultured keratinocyte allografts deficient in major histocompatibility complex antigens.
    Hultman CS; Hunt JP; Yamamoto H; Giannopoulos A; deSerres S; Frelinger JA; Meyer AA
    J Trauma; 1998 Jul; 45(1):25-33; discussion 33-4. PubMed ID: 9680007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tolerance that develops in recipients of cultured allografts is an active process that affects both the activation and effector function of cytotoxic T cells.
    Talmage DW; La Rosa FG; Smilek D; Ammons TJ
    Prog Clin Biol Res; 1986; 224():187-94. PubMed ID: 3491996
    [No Abstract]   [Full Text] [Related]  

  • 31. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
    Qian S; Lu L; Fu F; Li W; Pan F; Steptoe RJ; Chambers FG; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1998 Jun; 65(12):1590-8. PubMed ID: 9665075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine.
    Nobori S; Samelson-Jones E; Shimizu A; Hisashi Y; Yamamoto S; Kamano C; Teranishi K; Vagefi PA; Nuhn M; Okumi M; Wong B; Houser S; Sachs DH; Yamada K
    Transplantation; 2006 Jan; 81(1):26-35. PubMed ID: 16421473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
    Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
    J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance to cultured allografts protects third-party grafts containing new MHC and common minor antigens.
    La Rosa FG; Talmage DW
    Transplantation; 1987 Feb; 43(2):314-6. PubMed ID: 3580040
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced tolerance to allografts in mice. VI. Tolerance induction in H-2-haplotype-identical strain combinations in mice.
    Mayumi H; Himeno K; Shin T; Nomoto K
    Transplantation; 1985 Aug; 40(2):188-94. PubMed ID: 3895627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T; Hancock WW; Monaco AP; Maki T
    Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
    Nevala WK; Paul C; Wettstein PJ
    J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initiation of rejection of established islet allografts by third-party thyroid allografts and splenic dendritic cells.
    Kover K; Moore WV
    Diabetes; 1991 Jun; 40(6):754-8. PubMed ID: 2040391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
    Brochu S; Baron C; Hétu F; Roy DC; Perreault C
    J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.